| Literature DB >> 28569762 |
Olga T Schubert1, Hannes L Röst2, Ben C Collins3, George Rosenberger3, Ruedi Aebersold3,4.
Abstract
In this Perspective, we discuss developments in mass-spectrometry-based proteomic technology over the past decade from the viewpoint of our laboratory. We also reflect on existing challenges and limitations, and explore the current and future roles of quantitative proteomics in molecular systems biology, clinical research and personalized medicine.Mesh:
Year: 2017 PMID: 28569762 DOI: 10.1038/nprot.2017.040
Source DB: PubMed Journal: Nat Protoc ISSN: 1750-2799 Impact factor: 13.491